Onyx CEO Anthony Coles talks about cancer research and shares his personal story of fighting cancer. Anthony Coles, Andrew Ross Sorkin. Location: Paepcke Auditorium
Dr. Anthony Coles
Dr. Coles joined Onyx in March 2008 as President, Chief Executive Officer, and a member of its board of directors. Prior to joining Onyx, he was President, Chief Executive Officer, and a member of the board of directors of NPS Pharmaceuticals, Inc. Before joining NPS Pharmaceuticals in 2005, Dr. Coles was Senior Vice President of Commercial Operations at Vertex Pharmaceuticals Incorporated, which he joined in 2002. Beginning in 1996, he held a number of executive positions while at Bristol-Myers Squibb Company, including Senior Vice President of Strategy and Policy; Senior Vice President of Marketing and Medical Affairs, Neuroscience/Infectious Diseases/Dermatology; Vice President, Western Area Sales Cardiovascular and Metabolic Business Unit for U.S. Primary Care; and Vice President, Cardiovascular Global Marketing. From 1992 until 1996, Dr. Coles also held a number of positions of increasing responsibility at Merck & Co., Inc., including Vice President of the Hypertension and Heart Failure Business Group.
Andrew Ross Sorkin
Andrew Ross Sorkin is co-anchor of "Squawk Box," CNBC's signature morning program. Sorkin is also a financial columnist for The New York Times and the editor-at-large of DealBook, a news site he founded that is published by The Times.
Anthony Coles, CEO of pharmaceutical company Onyx, offers a brief opinion on the Patient Protection and Affordable Care Act -- otherwise known as "Obamacare." While Coles generally views the act as a positive development, he notes one additional area for reform.